Contact: contact@cardiosense.com Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.
External link for Cardiosense
1375 W Fulton St
Suite 650
Chicago, Illinois 60607, US
Cardiosense reposted this
We’re hiring! Join our Clinical Research Team as we create the future of non-invasive cardiovascular care and increase access to care. Reach out today to learn more! #Hiring #JobOpportunities #JoinOurTeam #LifeScience #DataScienceClinicalResearch #ChicagoClinicalResearch
We’re hiring! Join our Clinical Research Team as we create the future of non-invasive cardiovascular care and increase access to care. Reach out today to learn more! #Hiring #JobOpportunities #JoinOurTeam #LifeScience #DataScienceClinicalResearch #ChicagoClinicalResearch
Cardiosense reposted this
Hope is on the horizon for the more than 6 million Americans who are living today with heart failure, many of them elderly and in rural communities without access to cardiac specialists. At Cardiosense, we’re on a mission to help redefine the future for cardiology and democratize access to specialty care with a non-invasive approach to managing heart failure–both in-clinic and remotely–using highly predictive pressures within the heart . Watch for our two major presentations at TCT and the American Heart Association (AHA) conference in the coming weeks. We’ll reveal new research that showcases the impact of our AI-driven heart failure management platform that we believe will revolutionize cardiac care, making early detection and guided therapy more accessible to all. #HeartHealth #HeartFailure #Cardiology #DemocratizingSpecialtyCare #AIinHealthcare
Hope is on the horizon for the more than 6 million Americans who are living today with heart failure, many of them elderly and in rural communities without access to cardiac specialists. At Cardiosense, we’re on a mission to help redefine the future for cardiology and democratize access to specialty care with a non-invasive approach to managing heart failure–both in-clinic and remotely–using highly predictive pressures within the heart . Watch for our two major presentations at TCT and the American Heart Association (AHA) conference in the coming weeks. We’ll reveal new research that showcases the impact of our AI-driven heart failure management platform that we believe will revolutionize cardiac care, making early detection and guided therapy more accessible to all. #HeartHealth #HeartFailure #Cardiology #DemocratizingSpecialtyCare #AIinHealthcare
Today Cardiosense participated in the HRX 2024 Pitch Competition. Co-Founder and Chief Scientific Officer, Omer Inan, presented our groundbreaking approach to heart failure management which leverages wearable sensors and AI-driven algorithms designed to detect early signs of cardiac deterioration and improve patient outcomes. We’re excited to showcase our technology to and learn from many like-minded experts in the field who share our vision of a brighter future in cardiac care. #HRX2024
We are excited to announce that we will be participating in Heart Rhythm Society's HRX 2024 Pitch Competition! This event is an excellent opportunity to showcase the work being done by our incredible team here at Cardiosense. #HRX2024
Cardiosense reposted this
Hey Chicago - join us for a deep-dive conversation on A.I. in cardio care with Meesha Dogan, PhD, founder and CEO of Cardio Diagnostics Holdings Inc., and Amit Gupta, founder and CEO of Cardiosense. Meesha and Amit will join Portal’s Director of Venture Operations, Steven Lehmann in a conversation about monitoring, predicting, and measuring cardiac health and some of the awesome possibilities coming to market now. Register for the event here: https://lnkd.in/gBsZFUJW
We are proud to announce that Cardiosense has been awarded the "Best IoT Healthcare Wearable Device" in the 2024 MedTech Breakthrough Awards! This recognition underscores our commitment to advancing virtual cardiac care by developing novel, multi-modal sensors and advanced machine learning algorithms to detect early signs of cardiac disease and guide personalized therapy. A heartfelt thank you to our dedicated team and partners who share our vision for combatting preventable cardiac disease. Congratulations to all the amazing winners! https://cardiosense.com/
🎉 Exciting news from the world of digital health and medical technology innovation! 🏥 We’re thrilled to officially announce the results of our 8th annual MedTech Breakthrough Awards program. 🌟 This year's awards highlight the best and brightest in categories ranging from Patient Engagement to Medical Devices, showcasing the incredible impact of breakthrough new technology on patient care, clinical operations, and overall healthcare outcomes. To all of our 2024 MedTech Breakthrough Award winners - Your innovative spirit and dedication to excellence are driving transformative advancements that are reshaping the healthcare industry for the better. Congratulations, and here's to continued success and impact! 🚀 https://lnkd.in/gbg4fHRd #MedTechBreakthrough #HealthcareInnovation #DigitalHealth #MedTech
Cardiosense reposted this
HF is the leading cause of hospitalization among older adults and Medicare beneficiaries with HF have the highest readmission rate of any condition. It's estimated that nearly half of these hospitalizations can be avoided by optimizing outpatient therapy. Come join our mission in combatting preventable cardiac disease: https://lnkd.in/gdiGTFpi #HFWeek2024
HF is the leading cause of hospitalization among older adults and Medicare beneficiaries with HF have the highest readmission rate of any condition. It's estimated that nearly half of these hospitalizations can be avoided by optimizing outpatient therapy. Come join our mission in combatting preventable cardiac disease: https://lnkd.in/gdiGTFpi #HFWeek2024